Remove 2003 Remove Government Remove Medical Remove Provider
article thumbnail

The Supremes Give the FTC “Nothing but Heartaches”: Court Unanimously Rules No Restitution in Injunction Cases, and How Will This Ruling Impact FDA?

FDA Law

The Court also looked at the structure of the FTC Act beyond §13(b) to §5(l) and §19 which provide for the imposition of limited monetary penalties and awards of monetary relief where the FTC has already engaged in administrative proceedings. 129 (2003). FDA’s response to our 2003 article, authored by Eric M. 169 (2003).

article thumbnail

Palliative Care in India: M.R. Rajagopal

GeriPal

Raj: It was indeed very, very gradual, and the seeds were sown when I was a medical student. So, we formed this organization called Pain and Palliative Care Society in the Northern Kerala city of Kalakkad based in the government medical college. But when I retired from government service, I left Kalakkad in 2002.

Community 115
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Marijuana: Top Ten Reasons for Descheduling, Rescheduling or Not

FDA Law

The three letters together provide the range of actions DEA may take: no rescheduling from schedule I (former drug officials), rescheduling to schedule III (Democratic state attorneys general), or descheduling altogether (Democratic senators). and lacks an acceptable level of safety for use even under medical supervision.

Medical 59
article thumbnail

Aging and Homelessness: Margot Kushel

GeriPal

So we realized that we had a series of cross-sectional studies in San Francisco from the early 1990s to 2003. We looked at it and realized that in the early 1990s, 11% of folks were 50 and over, and by 2003, 37% were. In what moral universe is a federal government deeply subsidizing my housing and not subsidizing that of my patients?

article thumbnail

FDA Approves First State Drug Importation Program Under 20-Year-Old Statute, But High Hurdles Remain

FDA Law

After its enactment in 2003, successive administrations thwarted its implementation by declining to certify to Congress that importation will pose no additional risk to public health and safety and will result in a significant reduction in cost to American consumers, as the statute requires. See 21 C.F.R. 251.5; § 251.6(c).